Dr. Jeffrey Burns
Claim this profileUniversity of Kansas Medical Center
Studies Alzheimer's Disease
Studies Dementia
6 reported clinical trials
12 drugs studied
Area of expertise
1Alzheimer's Disease
donanemab
ApoE positive
ApoE negative
2Dementia
donanemab
Affiliated Hospitals
Clinical Trials Jeffrey Burns is currently running
Aducanumab
for Alzheimer's Disease
The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.
Recruiting1 award Phase 31 criteria
Alianza Latina Program
for Dementia
The research team will train primary care practitioners from Kansas City clinics to enhance skills in cultural competence, dementia detection, treatment and referral to a Health Navigator among Latinos 65 and older with dementia. The Health Navigator will provide patient/caregiver dyads referred by Alianza Latina providers with care management, psychosocial support and links to relevant community resources. Outcomes include feasibility and acceptability of 1) PCP training and 2) patient and caregiver dementia care.
Recruiting1 award Phase 1
More about Jeffrey Burns
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jeffrey Burns has experience with
- Donanemab
- No Intervention
- Aducanumab
- Placebo
- MK-6240
- NAV4694
Breakdown of trials Jeffrey Burns has run
Alzheimer's Disease
Dementia
Cognitive Impairment
Mild Cognitive Impairment
Nervous System Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Burns specialize in?
Jeffrey Burns focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved donanemab patients, or patients who are ApoE positive.
Is Jeffrey Burns currently recruiting for clinical trials?
Yes, Jeffrey Burns is currently recruiting for 2 clinical trials in Fairway Kansas. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey Burns has studied deeply?
Yes, Jeffrey Burns has studied treatments such as Donanemab, No Intervention, Aducanumab.
What is the best way to schedule an appointment with Jeffrey Burns?
Apply for one of the trials that Jeffrey Burns is conducting.
What is the office address of Jeffrey Burns?
The office of Jeffrey Burns is located at: University of Kansas Medical Center, Fairway, Kansas 66205 United States. This is the address for their practice at the University of Kansas Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.